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Dr Huillard et al. suggested that we report on mental health out-
comes in breast cancer survivors with and without history of
mental disorders. Twenty-two of the 60 studies excluded partic-
ipants with history of mental disorders. Of the 38 studies that
did not mention psychiatric history in their exclusion criteria,
three accounted for it either through matching or adjustment in
multivariable analyses; only one study explored the role of psy-
chiatric history (it showed no correlation between psychiatric
history and symptoms of posttraumatic stress).
Dr Huillard et al. noted that in a previous study, an increased
risk of mental disorders was only observed among cancer
patients who had a history of mental disorder (1). As noted
above, results stratified by psychiatric history were seldom
available in studies that we reviewed. However, we believe that
the results of the studies that included only participants with
no history of mental disorders are informative. Four
population-based studies included in our review, in which out-
comes were clinically ascertained, showed an increased risk of
anxiety and/or depression in breast cancer survivors with no
history of mental disorders, relative to comparable women
without cancer (2–5). This shows that for breast cancer survivors
(>1 year), the risk of first-ever disorders is increased relative to
women who never had cancer. If the hypothesis of Dr Huillard
et al. is correct, the burden of mental disorders is likely to be
underestimated in the studies restricted to women with no his-
tory of mental disorders. We should also note that our study fo-
cused solely on female breast cancer survivors at least 1 year
after diagnosis, whereas the Huillard et al. study included
patients with a wide range of cancers (16% were of the breast). It
is plausible that the effect of a cancer diagnosis on the patients’
mental health varies by cancer site. We thank Dr Huillard et al.
for their interest in our study.
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